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ABSTRACT

CIGARETTE SMOKE PROMOTES GENOMIC EVOLUTION
IN THE PERIODONTAL PATHOGEN
PORPHYROMONAS GINGIVALIS
Josh George
04/26/2013

P. gingivalis is an opportunistic, anaerobic, Gram-negative oral pathogen strongly
implicated in the pathogenesis of periodontal diseases. Clinical isolates of P. gingivalis
exhibit great genetic diversity. Tobacco smoking greatly increases the risk of P.
gingivalis infection. Furthermore, cigarette smoke extract (CSE) is an environmental
stressor for P. gingivalis, differentially regulating multiple genes including ones that
encode proteins involved in DNA translocation, replication and repair. Therefore, we
hypothesized that CSE exposure would promote genomic instability in this important
periodontal and systemic pathogen, which may contribute to increased virulence.
P. gingivalis W83 was passaged 50 times in CSE-conditioned medium after
which, genomic DNA was extracted and whole-genome sequencing was employed to
identify any chromosomal alterations induced by CSE compared to un-exposed controls.
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Whole genome sequencing identified 22 CSE-induced point mutations (p<0.05),
17 or which were confirmed as well as significant allelic variance (p<0.001) in CSE
versus control samples.

Our results indicate that CSE exposure promotes genetic

diversity in a laboratory strain of P. gingivalis. Should this phenomenon occur in vivo,
tobacco smoke could promote bacterial evolution and, thus, contribute to the emergence
of more virulent strains in this key periodontal pathogen, which may infect smokers and
non-smokers alike.
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CHAPTER ONE: INTRODUCTION AND LITERATURE REVIEW

The use of smoking tobacco is one of the most major and preventable causes of
premature mortality across the world [1,30]. Cigarette smoking and exposure to smoke is
associated with chronic diseases, economic losses to society, and a substantial burden on
the United States healthcare system, costing billions of dollars annually [1,2].
From the years 2000-2004, it is estimated in the United States that cigarette
smoking and cigarette smoke exposure resulted in 443,000 premature deaths, 5.1 million
years of potential life lost, and $96.8 billion in productivity losses annually [1]. One
study estimated nearly 25 percent of all deaths in the age group 35-69 are directly
attributed to smoking [30]. Studies have also implicated smoking as the primary causal
factor for at least 30 percent of all cancer deaths as well as 80 percent of all deaths from
chronic obstructive pulmonary disease and early-onset cardiovascular diseases [1].
Approximately one-third of the adult global population are tobacco users and 5-6
million people die annually due to tobacco-related illnesses [4]. While the use of smoking
tobacco has declined in the United States in recent decades [30], global use has increased
in developing nations [10]. Nearly 80 percent of annual tobacco related deaths occur in
middle- to low-income countries [3].
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Tobacco Smoke Toxicity
The serious ramifications of tobacco use come in the form of smoking related
diseases. Tobacco smoke puts users at increased risk for a wide range of diseases such as;
cardiovascular disease, oral, airway, and lung diseases, numerous cancers, immune
disorders, persistent infections, and numerous chronic inflammatory diseases [6,14,16,
28].
Increased health risks are directly attributed to the high toxicity of tobacco smoke.
The gaseous and particulate phases of cigarette smoke contain more than 4,500 chemicals
which include 70 known carcinogens, as well as other reactive solids, oxidative species
(free radicals), and mutagenic components [5-7]. Some of the more hazardous
components of tobacco smoke include; ammonia, carbon monoxide, carbon dioxide,
formaldehyde, acrolein, acetone, benzopyrenes, and hydroxyquinone as well as heavy
metals including cadmium and arsenic [5,6].
Smoking tobacco accounts for up to 85 percent of global tobacco production and
use, and is the most hazardous form of tobacco use as observed by the more severe and
diverse types of diseases when compared to smokeless tobacco [8].
Active smokers are not the only individuals at risk for adverse side effects from
tobacco smoke. Cigarette smoke is a major environmental pollutant and exposure to
second hand smoke has been linked to susceptibility to many of the same diseases
associated with active smoking in both adults and children [9,11,12,17]
The causticity of tobacco smoke and its status as a ubiquitous environmental
pollutant directly contribute to the global disease burden via its mutagenic capacity
(explained in later section) as well as multiple adverse effects on the innate and adaptive
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immune systems, greatly increasing the risk of chronic infectious and inflammatory
diseases [5,13,15-22] as will be discussed in the following sections.

Tobacco Smoke and Chronic Inflammatory Diseases

Tobacco smoke puts users at an increased risk for developing chronic
inflammatory diseases. While the mechanisms are not fully understood, studies have
associated smoking with inflammatory conditions such as acute vascular diseases [14,42],
inflammatory bowel disorders [6,21] renal disease [19], pancreatitis [20] and periodontal
diseases [41]. Studies also show smoke can deregulate endocrine and immune systems,
predisposing users to autoimmune inflammatory disorders such as primary biliary disease
(PBD), rheumatoid arthritis (RA), and multiple sclerosis (MS) [22,43,44].
Evidence has shown tobacco smoke deregulates and increases the expression of
several systemic pro-inflammatory markers indicated in chronic inflammation such as
elevated levels of serum fibrinogen and plasma C-reactive proteins, as well as proinflammatory cytokines and chemokines, which in turn leads to increased levels of
macrophages, monocytes, and neutrophils [44].
For example, smoke-induced stress on blood vessels increases vascular
permeability and activates increased adhesion molecule expression, resulting in increased
leukocyte adhesion and platelet aggregation eventually leading to atherosclerotic lesions
and thrombus formations greatly increasing the risk of heart attack and/or stroke
[14,42,48,49].
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Pulmonary dysfunction and chronic inflammation of the airways such as
emphysema and chronic obstructive pulmonary disorder (COPD) are also elicited by
tobacco smoke [47]. Smoke exposure on airway epithelia increases pro-inflammatory
cytokine expression, induces rapid influx of activated neutrophils and macrophages and
formation of free radicals, as well as release of degradative enzymes such as neutrophilic
elastase and matrix metalloproteases (MMPs) [40].

Tobacco Smoke and Infectious Diseases

Smokers as well as those exposed to environmental (second-hand) smoke are
more susceptible to contracting infectious diseases than non-smokers, such as respiratory
tract infections, pneumonia, tuberculosis, meningitis, bacterial sexually transmitted
diseases, and periodontal diseases to name only a few [17,25]. While there is a robust
amount of evidence correlating the effects of smoking adversely affecting human health,
there is a gap in knowledge, mechanistically to explain such phenomena [102].
It has been hypothesized that smoking increases the risk of infection by three
general mechanisms: tobacco-induced host physiological and structural changes,
deregulation of innate and adaptive immune systems, and increasing bacterial virulence
[17]. There is much evidence to support this hypothesis.
Cigarette smoke components and their metabolites such as acrolein, acetaldehyde,
formaldehyde, and free radicals are implicated in contributing to structural changes
observed in the respiratory tract, aiding bacterial colonization and infection [100,101].
Such changes include peribronchiolar inflammation and fibrosis, increased mucosal
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permeability and impairment of the mucociliary clearance. These structural changes
decrease the ability of the host to clear pathogens from the airways, aiding bacterial
colonization and infection [103].
Various structural changes can also be induced by cigarette smoke [17]. Clinical
evidence has shown cigarette smoke exposure causes cerebral vessels to dilate [95], while
causing peripheral arterial vessels constrict [46]. In the periodontal tissues, cigarette
smoke has been shown to suppress angiogenesis [57].
Cigarette smoke is also highly implicated in deregulating the innate immune
system.

Studies have shown tobacco smoke to decrease phagocytic activity and

generation of reactive-oxygen species in neutrophils and monocytes, suppressing their
responsiveness and bacterial-killing capacity, and consequently aiding pathogenic
colonization and infection [104-106].

Tobacco smoke also reduced dendritic cell

antigen-presenting and co-stimulatory molecules, and reduced capacity for antigen uptake
and production of T-cell stimulatory cytokines in murine models [107].
Adaptive immunity is also compromised upon exposure to tobacco smoke.
Reduced serum levels of Immunoglobulin G (IgG), an important anti-microbial antibody,
have been detected in smokers when compared to non-smokers [96,97].

T-cell

proliferative responses have also shown to be suppressed in smokers. Studies have
shown a decrease in the ratio of CD4 to CD8 lymphocytes in heavy smokers. This is
explained by a decrease in CD4 lymphocytes while there is a simultaneous increase in
CD8 lymphocytes [98,99]. Because CD4 lymphocytes stimulate B-cell proliferation and
differentiation as well as immunoglobulin synthesis, the decrease of CD4 lymphocytes in
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heavy smokers may be a possible explanation for the observed reduced serum IgG levels
in smokers [25].
Smoke may also induce increased bacterial virulence, contributing to increased
susceptibility of infection [17].

For example, smoke exposure induced increased

adhesion of respiratory pathogens to airway epithelial cells in smokers [108]. Smoke can
also induce shifts in microbial populations allowing pathogens to proliferate [109].
While there is still much research that needs to be conducted on the subject, there is
convincing evidence that tobacco smoke can both genotypically and/or phenotypically
alter pathogens and increase virulence. The effects of tobacco-induced alterations on the
genome, physiology, and virulence of the periodontal pathogen Porphyromonas
gingivalis will be discussed in detail in later sections.

Periodontal Diseases

Periodontal diseases are both infectious and inflammatory. Data from the World
Health Organization suggests that 5-20 percent of the adult global population suffers
from severe periodontitis and that most children and adolescents will exhibit signs of
gingivitis at some point in their lifetime [130].

A study using data from

the 2009 and 2010 National Health and Nutrition Examination Survey (NHANES)
estimated

the prevalence,

severity,

and

extent

of periodontitis in

the adult U.S.

population. The results indicated that roughly 47 percent adults aged 30 years or older,
had periodontitis, distributed as 8.7 percent, 30 percent, and 8.5 percent with mild,
moderate, and severe periodontitis, respectively. For adults aged 65 and older, 64 percent

6

had either moderate or severe periodontitis. This survey provides direct evidence of the
high burden of periodontitis in the United States [34].
Bacteria in the oral cavity often proliferate in an attached multispecies biofilm
community, commonly known as dental plaque. The composition of the microbiota in
biofilms can be altered due to factors such as diet, host genotype, antibiotic ingestion,
pathogen infection, and other environmental effects, which can greatly affect host
physiology, metabolism, and immune systems [117]. Periodontal disease and the
resulting inflammation is caused when Gram negative oral pathogens such as P.
gingivalis, Treponema denticola, and Tannerella forsynthia invade the gingival sulcus
between the junctional epithelium below the gingival margin and the clinical root of the
tooth, altering the commensal biofilm composition, and challenging the host immune
system [24,50] as shown in Figure 1. Subgingival colonization by these periodontal
pathogens is aided by the expression of several immune subverting virulence factors,
which will be discussed in a later section.
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Figure 1 shows what occurs during periodontal disease - accumulation of
pathogenic bacteria and biofilm formation that develops in the subgingival pocket. The
release of multiple pro-inflammatory cytokines (IL-1, TNF, IL-6, etc) are detectable and
are expressed in the gingival tissue as well as released into the gingival crevicular fluid
activating neutrophils, macrophages, and recruiting them to the site of infection
eventually leading to connective tissue matrix degradation and osteoclast activation
which leads to the degradation of bone.
There are progressive stages of periodontal disease that are characterized by the
severity of hard and soft periodontal tissue damage, such as bleeding on probing, pocket
depth, and gingival and alveolar bone resorption.

Gingivitis is the initial stage of

periodontal disease and is characterized by minor redness, swelling, and bleeding on
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probing. The minor inflammation of gingivitis is reversible and does not cause any
lasting or permanent damage [27]. However, if left untreated, gingivitis can progress into
the more severe form of periodontal disease, periodontitis. Periodontitis is characterized
by irreversible inflammatory damage of the periodontal tissues such as detachment of the
periodontal ligament, gingival resorption, and alveolar bone loss, eroding the supporting
structures of the teeth resulting in tooth mortality and tooth loss over time [23, 24].
The severity and progression of the inflammatory immune response varies
depending on host-specific factors. Things such as age, race, and immune abnormalities
are just a few of the important factors that affect the host immuno-inflammatory response
[29].
The colonization of the sub-gingival pocket by Gram-negative periodontal
pathogens stimulates secretion of pro-inflammatory cytokines such as IL-1, IL-6, IL-8,
TNF and RANKL from host oral epithelial cells [51] as shown in Figure 1. Proinflammatory cytokine secretion causes immediate swelling and redness of the
periodontal tissues. Inflammation becomes more severe as pathogens proliferate
promoting further, possible permanent tissue damage [23, 24, 27].
Bacterial persistence and prolonged cytokine secretion activate osteoclasts in the
host alveolar bone [37]. When osteoclasts become activated, bone matrix is broken down
causing irreversible bone resorption from the alveolar crest. If left untreated, bone loss
will continue apically toward of the root of the tooth [31]. The destruction of the
supporting tooth structure consequently causes loss of attachment resulting in tooth
mobility and eventual loss of the tooth [23,24].
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Tobacco Smoke and Periodontal Disease

Tobacco smoke is a major environmental pollutant and significant risk factor for
periodontitis. Accordingly, smokers have a high predisposition of developing plaqueinduced periodontal diseases and consequently a higher prevalence [29,32,33]. Tobacco
smoke is a major risk factor for periodontal disease because the oral cavity is the
entryway for smoke into the airways and therefore naturally has the highest concentration
of smoke components, especially in the gingival crevicular fluid (GCF) excreted from the
gingival sulcus [93].
Evidence suggest high concentrations of tobacco smoke components induces a
shift in periodontal plaque composition from one that is mainly constituted of Gram
positive, aerobic, commensal bacteria to one that contains more Gram negative, anaerobic
pathogens, such as P. gingivalis [50].
Studies show a clear dose-dependent relationship between smoking and
periodontal disease [35]. High levels of tobacco smoke inhalation are associated with
faster disease progression and more severe periodontal damage. Clinical evidence shows
increased gingival recession and alveolar bone loss, greater periodontal ligament (PDL)
attachment loss and deeper gingival pocket formation that is responsible for increased
tooth mobility and tooth loss at an earlier age than non-smokers [36,37]. It has also been
shown that patients who suffer from periodontal disease are much more likely to be
refractory to treatment if they are active smokers, when compared against non-smokers
[36].
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Various studies have been conducted which give insight into the link between
tobacco smoke and periodontal disease. Nicotine, a major smoke component has been
shown to induce periodontal collagen degradation by increasing expression of the
collagenase matrix metalloproteases (MMPs), which may result in detachment of the
periodontal ligaments [54]. Several studies have also indicated nicotine and one of its
major metabolites cotinine, adversely affect human periodontal fibroblasts (PDFs)
decreasing their levels of attachment, proliferation, and chemotactic responsiveness in a
dose-dependent manner [39, 52]. One study shows, upon exposure to nicotine stress
periodontal fibroblasts increase c-fos expression, to protect against cellular damage [55].
This same study suggests that the nicotine-dependent stress-specific expression of the cfos gene correlates with cellular thiol levels in human PDFs. Thiols are exceedingly
important in that they act as an antioxidant defense system to protect the cell against
oxidative damage.
Acrolein is another pernicious smoke component and major player in the
destruction of periodontal tissues. In a study conducted by Chang et al. [55], it was
shown that acrolein significantly depleted intracellular thiol levels in PDFs. Therefore,
decreased levels of thiol make the PDFs much more susceptible to damage by oxidants
contained in tobacco smoke. The same study also showed that acrolein can suppress PDF
proliferation by as much as fifty percent, resulting in significant attachment loss of the
periodontal ligaments.
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Tobacco Smoke and Periodontal Inflammation

Despite being more susceptible to periodontitis and exhibiting faster disease
progression and severity, chronic smokers lack the clinically overt inflammatory response
to bacterial plaque that non-smokers exhibit such as redness, swelling, bleeding on
probing and reduced pro-inflammatory indicators [56].

As discussed in previous

sections, tobacco smoke is a major environmental toxin and as such, has the ability to
alter the user’s inflammatory responses by deregulating the innate and adaptive immune
systems.
Evidence suggests that tobacco smoke deregulates important sequential adhesion
molecule cascades that are critically important for leukocyte recruitment and causes
inappropriate leukocyte activation [57]. Therefore, normal inflammatory reactions may
be compromised.

Cigarette smoke also induces local suppression of angiogenesis,

providing a possible explanation for reduced amounts of bleeding [56, 58].
All of these observations make it apparent that tobacco smoke plays an important
role in the pathogenesis and severity of periodontal disease. However, the mechanisms by
which tobacco smoke masks periodontal inflammation warrants further investigation
[56]. Much of the research on the matter has been directed towards the host response to
smoking and periodontal infection. However, it is poorly understood how tobacco smoke
affects periodontal pathogens and what affect this has on their virulence in pathogens
such as P. gingivalis.

12

Porphyromonas gingivalis

Porphyromonas gingivalis is an opportunistic, Gram-negative, assacharolytic,
anaerobic oral pathogen highly implicated in the pathogenesis of periodontitis and
systemic sequelae.

Socransky et al. 1998 characterized periodontal microbial

communities based on cluster analysis, community ordination and associated disease
severity. The periodontal bacteria were then categorized into five separate color-based
complexes which increase in severity of disease association in the following order;
purple, yellow, green, orange, and red. P. gingivalis is a member of the “red complex”
which also includes T. denticola and T. forsythia.
Numerous studies have detected these three oral pathogens as being strongly
associated with each other and with severe disease sites [66]. Due to the ease of growth
and ability to be genetically manipulated, P. gingivalis has become the most well studied
out of the three oral bacteria in the red complex [74].
Further analysis of P. gingivalis has led to its designation as a keystone pathogen.
A validated murine model study [112] provides evidence that P. gingivalis, even at low
abundance has the ability to significantly induce alterations to host commensal
microbiota in a way supports its own viability while promoting disease pathogenesis. In
these models, specific pathogen free (SPF) mice inoculated with P. gingivalis caused
significant bone loss which is a defining characteristic of periodontal disease. In contrast,
germ free (GF) mice inoculated with a P. gingivalis mono-infection saw no significant
bone loss indicating that P. gingivalis alone cannot induce periodontitis. This study
indicates that rather than directly attacking host periodontal tissues, P. gingivalis

13

contributes to disease indirectly by significantly altering the total commensal microbial
load and biofilm composition, which overwhelms normal host tissue-protective
mechanisms and homeostasis, resulting in an immune-inflammatory response, promoting
disease pathogenesis.

P. gingivalis Genome

Nelson et al. [110], sequenced the complete 2,343,479-bp genome of P. gingivalis
strain W83, a highly virulent strain used in experiments conducted for this thesis. The
W83 genome contains 2,015 genes, encoding 1,990 and has an average G/C content of
48.3%. There are four ribosomal operons and two structural RNA genes, as well as 53
tRNA genes with specificity for all 20 amino acids. Analysis revealed a total of 1,990
open reading frames (ORFs) approximately 85% of the genome. Of these ORFs, 1,075
were assigned biological roles, 184 were conserved hypothetical proteins or conserved
domain proteins, 208 had unknown functions, and 523 encoded hypothetical proteins.
Repetitive elements were revealed including DNA repeats {direct repeats and
clustered regularly interspaced short palindromic repeats (CRISPRs)} as well as
transposable elements {Insertion sequences (ISPg1-11) and miniature inverted-repeat
transposable elements (MITE239, MITE464, MITE700)}. Repetitive and transposable
elements occupy approximately 6% of the genome. It was revealed that 96 complete or
partial copies of IS elements are present within the genome. However, it was indicated
they are rarely found in functional genes and instead are inserted almost exclusively into
intergenetic regions (IGRs) and other copies of transposable elements.
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Further analysis indicated 21 areas of the genome that displayed atypical
nucleotide composition based on increased and/or decreased levels of G/C content when
compared to the rest of the genome. The investigators believed a variety of genes could
possibly have been acquired through lateral gene transfer and are encoded in these
regions. These genes include restriction system proteins, hemagglutinin proteins B and C,
numerous capsular biosynthesis proteins, 20 transposase genes, and two large mobile
elements.

Clinical P. gingivalis Strain Variants

Genotypic characterization of P. gingivalis strains has revealed extensive genetic
variability [72]. A study by Griffen et al. [114], used heteroduplex analysis of the
ribosomal internal spacer region (ISR) between 16S and 23S ribosomal genes of P.
gingivalis to detect strain variants as well as determine if all strains exhibit similar
strengths of association with periodontal disease or rather if there are more- and lessvirulent strains. P. gingivalis samples were collected from patients with clear indicators
of periodontal disease as well as age-matched, healthy, control patients.

Analysis

revealed eleven P. gingivalis heteroduplex types, of which six types had sufficient
numbers for statistical analysis. It was determined type hW83 was the most strongly
associated with periodontal disease. Additionally, types h49417 and hHG1691 were also
significantly associated with periodontitis but with lower odds ratios than hW83. The
remaining three types h23A4, h381, and hA7A1 were not significantly associated with
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disease pathogenesis. The results of these analyses indicate there are in fact differences
in virulence between clinical strains of P. gingivalis.
A more recent study conducted by Igboin et al. [113] confirmed the previous
study’s findings as well as used ISR heteroduplex analysis to determine worldwide
genetic variability and distribution of P. gingivalis. In this study, samples were taken
from patients at 3 U.S locations (Columbus, Ohio/San Antonio, Texas/San Francisco,
California) as well as from foreign college students entering the U.S. who had arrived no
more than 30 days prior to taking plaque samples. Heteroduplex analysis confirmed the
six predominant heteroduplex types {W83 (including strain W50), 23A4, A7A1, 381
(including strain ATCC 33277), HG1691, and ATCC49417} of the previous study in all
U.S. locations as well as foreign continents, with 14 rare heteroduplex types showing up
in only one or a few locations.
Furthermore,

investigators

used

microarray-based

comparative

genomic

hybridization (CGH) to analyze whole genome variability of the major heteroduplex
strains. Using strain W83 as the control, it was found that the control genome was highly
conserved among the major heteroduplex types ranging between 0% variability when
compared with strain W50 to 5.1% when compared to strain ATCC 33277. Both ISR and
CGH revealed strains ATCC 49417 and W50 to be very closely related to strain W83,
respectively.
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P. gingivalis and Periodontal Disease

Studies have shown more than 700 species of bacteria can colonize the oral
cavity, while only a small number are associated with disease [65].

Of these, P.

gingivalis is strongly implicated in the development and progression of periodontal
disease. It is widely believed that polymicrobial interactions within dental plaques are
may be responsible for the initiation and progression of inflammatory periodontal
diseases [119]. Unfavorable alterations in periodontal biofilm communities, such as
pathogenic outgrowth of a keystone species like P. gingivalis, deregulate host
homeostasis [112,121-122]. P. gingivalis exhibits aggregative properties and several
virulence factors which aid in colonization and tissue destruction such as fimbriae,
proteases, lipopolysaccharides, and capsular polysaccharides [119].

Based on these

properties and clinical observations, P. gingivalis is considered an opportunistic pathogen
that is significantly associated with periodontal disease [65].

It is often isolated from

plaque biofilms removed from tooth surfaces in individuals with periodontal disease (7990%) while rarely found in healthy individuals (10-25%) [113].
Several studies have linked the association of P. gingivalis with periodontal
disease. P. gingivalis has been positively correlated with gingival pocket depth formation
in humans indicating there is an approximate 10-fold increase of P. gingivalis cells per 1millimeter of increased pocket depth in diseased sites [116]. A review of several animal
studies revealed P. gingivalis induced inflammatory immune responses and periodontal
bone loss in these models [120]. It has also been shown that reducing the numbers of P.
gingivalis cells via clinical scaling and root planing reduced clinical symptoms of
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periodontal disease such as gingival redness, bleeding on probing, and pocket depth
[123].

P. gingivalis Invasion, Proliferation, and Virulence

P. gingivalis Invasion and Proliferation
P. gingivalis has the ability to invade host periodontal tissues while evading host
defenses. In doing so, it causes deregulation of the host immuno-inflammatory responses
[50]. The following sections will discuss the invasiveness of P. gingivalis and its ability
to evade host defenses as well as the role of its major virulence factors including the
capsule, gingipains, fimbriae, and lipopolysaccharides (LPS).
P. gingivalis is able to actively invade host cells such as human gingival epithelial
cells, where it can avoid immune surveillance, replicate, and stay viable within the host
cell [62,67]. P. gingivalis also has the ability to invade macrophages, but does not
replicate as frequently as within other cells [64]. P. gingivalis uses its major fimbriae to
invade host cells. These major fimbriae bind with host cell-surface β1 integrins where P.
gingivalis can then rearrange the host cell’s cytoskeleton allowing it to internalize and
move from cell to cell via cytoskeleton bridges [63].

Evidence has shown that P.

gingivalis remains viable within host cells as there is no evidence of necrosis or
apoptosis. P. gingivalis has the ability inhibit gingival epithelial cell apoptosis induced by ATP ligation of P2X7 receptors. This is accomplished through secretion of an ATPhydrolyzing enzyme, suppressing host cell ATP-dependent apoptosis [62]. The ability of

18

P. gingivalis to internalize itself in host cells and remain viable while subverting immune
surveillance greatly influences its survival and proliferation in the periodontal pocket.

P. gingivalis Capsule
Strains of P. gingivalis are very heterogeneous and some of these strains,
including W83, produce an extracellular capsular polysaccharide (CPS), also known as
its K-antigen or serotype. There are at least six different known serotypes, which are
characterized by the capsules ability to generate systemic IgG antibody responses.
Encapsulated strains of P. gingivalis are shown to be highly invasive, while being
able to evade the host pro-inflammatory immune response [50]. In murine models,
encapsulated strains of P. gingivalis were associated with increased abscess formation
and spreading infection when compared to non-encapsulated strains, which only induced
localized abscesses [68].
In a study by Brunner et al. [61], the role of the P. gingivalis W83 capsule in
evading the innate immune response was studied. An espC gene-knockout mutant was
constructed for P. gingivalis W83; espC is located at the end of the capsular synthesis
locus inhibiting formation of the capsule. The wild-type strain and the espC mutant
challenged human gingival fibroblasts (HGFs) and the expressions of IL-1β, IL-6, and
IL-8 transcription levels were measured. Results indicated high cytokine and chemokine
transcription levels were found when the HGFs were challenged with the espC knockout
than with the wild-type strain. This evidence suggests that the capsule may help mask P.
gingivalis from the host pro-inflammatory immune response, helping to promote
virulence.
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Such a mechanism is especially important in the case of infectious chronic
inflammatory diseases such as periodontal disease in which evading the host immune
response helps P. gingivalis proliferate and persist while avoiding immune clearance
[59]. However, the potential involvement of the capsule in the overall deregulation of the
host response needs further study [50].

P. gingivalis Proteases (gingipains)
P. gingivalis produces trypsin-like cell surface cysteine proteinases, also known
as gingipains. Gingipains can account for up to 85% of the proteolytic activity of P.
gingivalis. Based on substrate specificity, they are divided into arginine-specific (Arg-X)
and lysine-specific (Lys-X) gingipains coded by the rgpA, rgpB, and kgp genes,
respectively [69].
Gingipains play an important role in the virulence of P. gingivalis while also
deregulating the host immuno-inflammatory response.

Gingipains are capable of

cleaving T-cell receptors such as CD4 and CD8, thereby greatly inhibiting cell-mediated
immunity [71]. They also have the ability to degrade cytokines and complement pathway
proteins conceding increased resistance to bacterial clearance from the host immune
response [50].
Aside from evading immune surveillance, gingipains may be directly involved in
the ability of P. gingivalis to invade host cells. Evidence has shown rgp to mediate P.
gingivalis adherence to oral epithelial cells. Evidence also shows once P. gingivalis has
invaded the host cell, expression of gingipains is reduced [70].
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Gingipains may also affect vascular permeability and the blood coagulation
system causing increased bleeding at the periodontal site perpetuating inflammation and
gingival edema [50].

P. gingivalis Fimbriae
The major ﬁmbriae of P. gingivalis are thin, hair-like ﬁlamentous cell-surface
structures encoded by the fimA BCDE operon. P. gingivalis fimbriae facilitate its ability
to adhere to salivary proteins, extracellular matrix, oral epithelial cells, and bacteria of the
same or other species. Through its ﬁmbriae, P. gingivalis can adhere itself to early
colonizing bacteria, and participate in the developing bioﬁlm structure making it essential
for invading and colonizing the host [74].
There are both major and minor fimbriae. Studies show major fimbriae play an
important role in colonization and invasion, while minor fimbriae are indicated in
activating the host inflammatory response [50]. Based on genomic variations of the fimA
gene, major fimbriae have been classified into six types (Type I-V, Ib) [73,74]. Minor
fimbriae are encoded from the mfa gene (mfa1, mfa2) [78]. Type II, major fimbriae is
found to be the most virulent and commonly associated with severe periodontal disease
[75].
Alveolar bone resorption is a hallmark of periodontitis.

Murine models of

periodontitis directly indicate P. gingivalis major (type II) and minor (mfa1) fimbriae in
the induction of alveolar bone destruction [77]. Other characteristics of major and minor
fimbriae are the capacity to evoke a pro-inflammatory cytokine response (IL-1, IL-6, IL8, and TNF- α) from various host cells as well as expression of matrix metalloproteases
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[50]. Major fimbriae induce increased expression of adhesion molecules from host oral
epithelial cells promoting further adhesion and invasion of host cells by P. gingivalis
[79]. P. gingivalis fimbriae have also proven to be an important virulence factor for
survival, interacting with complement receptor 3 (CR3) inhibiting IL-12 secretion from
host immune cells increasing resistance against immune clearance [76].

P. gingivalis Lipopolysaccharide (LPS)
Toll-like receptors (TLRs) play a pivotal role in initiating host immune responses
and are implicated to be involved in the development of many infectious diseases, such as
periodontitis [80]. P. gingivalis LPS is a key inflammatory mediator. Studies have
shown P. gingivalis LPS to be recognized by TLR2 and TLR9, while there is debate over
TLR4 recognition [80,81]. P. gingivalis LPS stimulates pro-inflammatory cytokine
secretion from host immune and oral epithelial cells, including IL-1, IL-6, IL-8, IL-18,
and TNF-α [50]. It is also implicated in alveolar bone loss [82], as well as increasing risk
the risk of systemic disease such as atherosclerosis [83].
P. gingivalis LPS is a weaker inducer of inflammation and pro-inflammatory
cytokine secretion than LPS of other Gram-negative bacteria, such as Escherichia coli
[84]. While most gram-negative LPS’s are strong TLR4 inducers, P. gingivalis LPS
primarily activates TLR2 and may even serve as an antagonist to TLR4 [85,86].
Evidence indicates this is due to structural LPS heterogeneity found within the acylation
patterns of the lipid A portion of P. gingivalis LPS. There are two known forms of P.
gingivalis LPS lipid A - penta-acylated and tetra-acylated. Studies show penta-acylated
lipid A acts as an agonist on TLR4, while tetra-acylated lipid A acts antagonistically
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against TLR4, modulating the host immune response [85, 87]. Variations in acyl chain
length have also shown to alter host immuno-inflammatory activity [88].

These

alterations to the lipid A portion of P. gingivalis LPS, as well as the host immune
response can be strain specific or environmentally induced by things such as hemin
concentration [88,89].

Tobacco Smoke and Bacterial Genomic Stability

A study conducted by Aufderheide et al. [90] examined the bacterial mutagenic
and cytotoxic capabilities of cigarette mainstream whole smoke and its gas/vapor phase
using a modified Ames assay (bacterial reverse mutation assay).

Standard S.

typhimurium bacterial tester strains were used: TA98, TA100, TA1535, TA1537,
TA1538, TA102, as well as descendant strains of TA98 (YG1021, YG1024, YG1041)
and TA00 (YG1026, YG1029, YG1042). WP2uvrApKM101, an E. coli strain, was also
used.
The mutagenicity of WS smoke was detected using (TA1538) TA98, (TA1535)
TA100 strains and their YG descendants as well as WP2uvrApKM101 in the presence of
S9 mix (metabolic activating system) and the plasmid pKM101, requiring a frame-shift
mutation. To detect mutagenicity in GVP, TA100 and descendent strains as well as
WP2uvrApKM101 were used in the presence of the pKM101 plasmid and the absence of
S9 mix, requiring a missense mutation. Based on the addition of S9 mix to WS analysis,
investigators implicated that many of the components need to be metabolized before

23

exerting mutagenic activity. Oppositely, the absence of S9 in the GVP analysis indicates
many of the mutagenic components are direct acting.
The results of WS analysis revealed that all strains showed genetic mutations
(induction of revertants). Mutagenic activity increased in a dose-dependent manner to a
maximum point that varied among different strains after which point the WS induced
toxic effects. GVP analysis also revealed genetic mutations. Missense mutations were
detected in WP2uvrApKM101 as well as strains TA1538, TA100 and its YG descendants
apart from YG1026.
Further analysis using several brands of cigarettes revealed that increased levels
of tar increased the mutagenic capacity of the cigarette smoke in most cases. Investigators
determined that tar content alone is not solely responsible for increased mutation. Rather,
the composition of the tar such as different types of tobacco, nitrate levels, etc. as well as
cigarette components and function such as filters and ventilation are responsible for
mutagenic capacity [90].

These findings are in line with previous studies [91,92]

conducted to determine the mutagenic capabilities of cigarette smoke.
The effects of tobacco smoke on the genomic stability and virulence of the
periodontal pathogen P. gingivalis is explained in the following sections.

Tobacco Smoke and P. gingivalis Genome, Physiology, and Virulence

P. gingivalis Genome and Physiology
The previous sections have discussed the toxicity of tobacco smoke and the
impact tobacco smoke has on deregulating host immuno-inflammatory responses to
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bacterial infections such as periodontal disease. However, little is known about the
effects tobacco smoke has on bacterial physiology and genomic stability and the role it
plays in disease pathogenesis, such as with the periodontal pathogen P. gingivalis.
A study by Bagaitkar et al. [115] investigated the effects of cigarette smoke
extract (CSE) on gene expression in P. gingivalis. Using microarray analysis, it was
discovered that 6.8% of the P. gingivalis genome was differentially expressed upon
exposure to CSE. A total of 104 genes were significantly differentially expressed by a
minimum of two-fold or greater. Of which, CSE induced expression of 58 genes while
suppressing 46.
Analysis revealed many of the genes induced by CSE had known or putative
functions, several of which were located within operons or were functionally related. Of
the 58 genes induced by CSE, two genes were identified in the major fimbrial operon, as
well as an operon encoding outer-membrane antigenic lipoproteins.

Groups of

functionally related genes were also identified such as in DNA replication and repair
genes (ruvC, radC, and a putative integrase), genetic insertions and transpositions (traE,
traF, and traK), as well as insertion sequences (ISPg3, ISPg5, and ISPg6). Several other
transfer (tra) genes were up-regulated but fell below the two-fold threshold. Numerous
genes involved in host-pathogen interactions and virulence were also up-regulated such
as proteases (tpr, trpT, and PG0317), two putative lipoproteins required for major
fimbriae assembly, and the major 61 and 63kDa surface antigens as well as other cell
surface polypeptides.
Of the 46 genes suppressed by CSE exposure, many encoded hypothetical
proteins whose functions are unknown. However, two genes were located within the
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capsular synthesis locus; capK, PG0111 (polysaccharide synthesis gene), and PG0108
(polysaccharide transport protein). Additionally, two other capsular synthesis genes were
also down-regulated upon CSE exposure but fell just below the two-fold limit. hmuR, a
tonB-dependent hemoglobin receptor was also down-regulated as well as fimS, a sensor
histidine kinase which is believed to be involved in regulating the expression of the major
and minor fimbrial operons.
In addition to microarray analysis, a cellular membrane fragment was analyzed by
SDS gel electrophoresis, which after analysis revealed overexpression of three bands that
were identified as RagA, RagB, and a putative lipoprotein (PG1079) that is believed to be
co-expressed with the minor fimbrial antigen.
It was concluded that the a number of the genes differently regulated by CSE
exposure are associated with aspects of P. gingivalis virulence such as fimbrial and
capsular operons, transcriptional regulators, transport proteins, proteases and cell capsule
proteins as well as up-regulation of several insertion sequence (IS) elements induced by
CSE promote genetic rearrangements. It is believed that the genomic response to CSE
exposure may partially explain the reduced inflammatory potential and altered hostpathogen interaction of P. gingivalis exhibited in smokers with periodontal disease.

P. gingivalis Virulence
The previous section described how P. gingivalis adapts to tobacco-induced stress
by altering the expression of several genes and outer membrane proteins involved in
virulence, which may serve to lower its inflammatory potential while increasing its
virulence. The microarray study revealed that CSE induced proteolytic activity, which
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may contribute to increased virulence. Also, major fimbrial genes (PG2133, PG2134)
were induced, while several genes associated with capsular biosynthesis (capK, wecC,
PG0117, PG0118) were suppressed [115,126].
P. gingivalis colonization of the oral cavity is dependent upon its interaction with
other plaque bacteria, including Streptococcus gordonii [119,124]. Another study by
Bagaitkar et al., 2011 hypothesized that cigarette smoke promoted P. gingivalis-S.
gordonii biofilm formation in a FimA-dependent manner. The previous microarray
analysis revealed while major fimbriae expression was significantly increased, minor
fimbriae function was unaffected [115].

Experimental evidence revealed that P.

gingivalis biofilms grown in the presence of CSE exhibited a significantly lower proinflammatory capacity (TNF, IL-6) and bound more strongly to immobilized rGAPDH,
the cognate FimA ligand on S. gordonii, than control biofilms in a dose-dependent
manner. Nevertheless, a peptide representing the minor fimbrial binding site on S.
gordonii, (SspB), completely inhibited dual species biofilm formation. Investigators
concluded that CSE likely augments P. gingivalis biofilm formation by increasing major
fimbrial avidity, which, in turn, supports initial interspecies interactions and promotes
subsequent high affinity Mfa1-SspB interactions driving biofilm growth. CSE induction
of P. gingivalis biofilms of limited pro-inflammatory potential may explain the increased
persistence of this pathogen in smokers [124].

Additionally, evidence suggests P.

gingivalis capsule production decreases ability of biofilm growth [125]. P. gingivalis
capsular biosynthesis genes (capK, wecC, PG0117, PG0118) were suppressed [115,126],
which may also serve to help promote P. gingivalis biofilm growth and proliferation.
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Lipid A heterogeneity of P. gingivalis lipopolysaccharides (LPS) are also
implicated in P. gingivalis virulence and inflammatory potential [128].

Evidence

suggests tobacco smoke has the ability to induce alteration in the Lipid A region of P.
gingivalis LPS reducing inflammatory potential, therefore increasing virulence [127].
A study by Buduneli et al. [127] analyzed fatty acid profiles of periodontal
bacteria from salivary samples from individuals with and without periodontal disease,
with a subset of active smokers and non-smokers in each group. It was revealed that the
acyl chain length of 3-OH fatty acids attached to the lipid A portion of bacterial LPS
significantly affects inflammatory response in periodontal bacteria.

Short straight-

chained fatty acids (12-14 carbons in length) had the highest potency in instigating an
inflammatory response, while longer chains (17 carbons in length) showed significantly
reduced inflammatory potential.
A study by Herath et al. [129] also gives evidence that structural lipid A
heterogeneity in P. gingivalis can reduce its inflammatory potential by examining how P.
gingivalis LPS lipid A heterogeneity differentially modulates the expression of IL-6 and
IL-8 in human gingival fibroblasts (HGFs).

HGFs were stimulated with

P. gingivalis tetra-acylated LPS (1435/1449) and penta-acylated LPS (1690) in a dose
dependent manner. Results indicated that penta-acylated LPS (1690) significantly upregulated the mRNA and protein expression of IL-6 and IL-8, whereas the tetra-acylated
LPS (1435/1449) did not induce significant host response. Because tobacco smoke has
the ability to alter acyl chain length [127], it can be easily hypothesized that tobacco
smoke may also influence P. gingivalis LPS lipid A acylation. P. gingivalis LPS lipid
A heterogeneity may differentially modulate
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pro-inflammatory

cytokine

expression,

allowing P. gingivalis subvert immune surveillance contributing to increased virulence
and periodontal pathogenesis. [85,87,129].

Tobacco Smoke, P. gingivalis, and Periodontal Disease

Our main objective in this thesis was to identify potential genomic instability and
genetic rearrangements and alterations induced by cigarette smoke extract (CSE) in the
periodontal and systemic pathogen Porphyromonas gingivalis, which is a keystone
pathogen

and

strongly

implicated

in

periodontal

disease

pathogenesis

[112,113,116,120,123]. CSE is an environmental stressor to P. gingivalis and upon
exposure, up-regulated 58 P. gingivalis genes [115]. Of these, groups of genes encoding
proteins involved in DNA translocation, replication and repair such as ruvC (PG1324), a
putative integrase (PG0817), and radC (PG0894), as well as members of the tra family of
proteins, traE (PG1483), traF (PG1482), and traK (PG1478) were up-regulated, which
may indicate genomic instability and genetic alterations and repairs upon CSE exposure.
Of particular interest to us was the up-regulation of insertion sequences (IS) ISPg3
(PG0299), ISPg5 (PG0943), and ISPg6 (PG1061).
Insertion sequences are relatively short sequences of DNA between 800 and 2,500
base pairs long and can greatly contribute to genomic variability and evolution. IS
elements contain at least one open reading frame, which encodes a transposase enzyme
that allows the IS element to move throughout the genome in either a cut-and-paste or
copy-and-paste fashion.
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Study Hypothesis

Our main hypothesis is that exposure of cigarette smoke (CSE) would induce
mutations and allelic variance in P. gingivalis. If so, we would establish that tobacco
smoke may promote bacterial evolution with the potential for the emergence of more
virulent clinical strains which may infect smokers and non-smokers alike.
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CHAPTER TWO: MATERIALS AND METHODS

Materials

	
  P. gingivalis W83 was purchased from the American Type Culture Collection
(Manassas, VA); P. gingivalis growth medium - Gifu Anaerobic Medium (GAM), was
bought from Nissui Pharmaceutical (Tokyo, Japan). 3R4F standard reference cigarettes
were obtained from the Kentucky Tobacco Research and Development Center
(Lexington, KY). ). The Wizard genomic DNA purification kit came from Promega
(Madison, WI). Primers were ordered from Bio-Synthesis, Inc. (Lewisville, TX).

Bacterial Culture and In Vitro Modeling of Tobacco Exposure

Porphyromonas gingivalis W83 was maintained as frozen stock culture. P.
gingivalis was then grown in GAM or GAM conditioned media with cigarette smoke
extract (GAM-CSE) under anaerobic conditions (80% N2, 10% H2, 10% CO2) at 37°C in
a Coy Laboratories (Grass Lake Charter Township, MI) anaerobic chamber. P. gingivalis
cells were harvested at mid- to late-exponential phase (OD600 = 1.0, corresponding to 109
cells per ml). GAM-CSE media was prepared using 3R4F reference cigarettes. Cigarette
smoke was drawn through 50mL of GAM using a syringe, and a three-way stopcock, in
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35mL drags every 20 seconds as described previously [115]. One cigarette was smoked
per 50mL of media. The CSE-conditioned medium was filtered (0.22mm) and diluted to
a concentration of 4000 ng ml nicotine. Nicotine content was determined by gas–liquid
chromatography as described previously [133], and adjusted to pH 7.2. Upon reaching an
OD600 of 1.0, P. gingivalis was sub-cultured into fresh GAM-CSE until 50 passages were
completed.

Isolation of Genomic DNA
Genomic DNA was isolated from 1.5 ml bacterial culture (OD600 = 1.0,
approximately 109cells/ml) after 50 passages in GAM-CSE with the Wizard genomic
DNA purification kit according to manufacturer’s instructions.

Whole Genome Sequencing

The complete genomic sequences of both control and CSE-exposed P. gingivalis
(after 50 passages in GAM or GAM-CSE) were obtained using the Illumina HiSeq2000
sequencing platform with paired end sequencing and a read length of 100 base pairs. The
paired end reads from the control and CSE treated samples were mapped, respectively,
using the BWA program ([http://bio-bwa.sourceforge.net/] version 0.6.1) to the P.
gingivalis

W83

assembly

NC_002950.2

(http://www.ncbi.nlm.nih.gov/nuccore/NC_002950.2). The mapping process consisted
first of running BWA program on each fastq file, followed by a run of sampe to create a
SAM file from the R1 and R2 read pairs. The resulting SAM file was converted to a
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BAM file and sorted using Samtools ([http://samtools.sourceforge.net/] version 0.1.18).
PCR duplicates were identified in each BAM file and removed using Picard Tools
([http://picard.sourceforge.net/] version 1.65) Mark Duplicates.

Insertion and deletion

(Indel) targets were identified using the Genome Analysis Toolkit (GATK)
([http://www.broadinstitute.org/gatk/] version 1.5) Realigner Target Creator.

These

targets were then fed into GATK Indel Realigner. These cleaned reads were then run
through Samtools mpileup to create pileup files, which were used to derive absolute allele
counts at each position for the respective BAM files. The de-duplicated, realigned BAM
files were loaded into the Intrepid Bioinformatics data management system, and may be
viewed in their entirety at:

Control:
http://server1.intrepidbio.com/FeatureBrowser/ngsdatasetrecord/record?ngsrecord=64411
08798
CSE:
http://server1.intrepidbio.com/FeatureBrowser/ngsdatasetrecord/record?ngsrecord=64411
08803

Confirmation of Point Mutations

Confirmation (i) – Visual Inspection
Each statistically significant identified mutation was viewed in Integrative
Genomics Viewer (IGV) [intrepidbio.com] to view the position of the mutations within
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the read as well as the read lengths to determine possible sequencing errors and
misalignments.

Confirmation (ii) – BLASTn
A nucleotide BLAST search [http://blast.ncbi.nlm.nih.gov/] was also conducted at
for each significant mutation read sequence to control for alignment errors.

Confirmation (iii) – Allele Specific PCR
The presence of the variant alleles were also confirmed using allele specific PCR,
when possible. PCR reactions were performed in triplicates as described by Calero et al.
[136] using 50ng of template DNA, 0.3µM of each Primer and 12.5µl of RT2 SYBR
Green ROX Mastermix on an Applied Biosystems 7500 Real-Time PCR System
(Invitrogen, Carlsbad, CA) under following conditions: 2min at 50˚C, 10min at 95˚C, 40
cycles of 15sec at 95˚C and 1min at 55˚C, with data collection during the 55˚C step. A
dissociation stage followed each run to allow for the analysis of melting curves. Changes
in cycle threshold (Ct) values were calculated by subtracting the mean Ct value of the
variant alleles from the mean Ct value of the control alleles (Ctvariant – Ctcontrol = ΔCt).

Statistical Analyses

Mutations
Sequence variants were screened for statistical analysis using the genome analysis
toolkit (GATK), to identify sequence variants in the CSE and control population samples.
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Allele and insertion / deletion counts from these 190 sequence variants were analyzed for
differences in allele or insertion / deletion frequency between control and CSE samples
using chi-squared tests of the 2x2 table consisting of the two most common alleles or the
most common allele along with insertion / deletion count. Corresponding p-values were
adjusted for multiple comparisons using the Benjamini-Hochberg approach [134], which
controls the false-discovery rate.

Allele frequency/Read Variance
The mean- and median- percent variation from the reference allele
(http://www.ncbi.nlm.nih.gov/nuccore/NC_002950.2) (referred to as the ‘minor allele
frequency’) was calculated across all nucleotides separately for both CSE and control
samples genomes. Simulated allele counts were generated at each position using an
averaged minor allele frequency between CSE and control samples. Each nucleotide was
treated as independent. Minor allele frequencies were then averaged across the genome
for each of these simulated CSE and control genome counts. This was repeated 1000
times, and then this distribution of differences between CSE and control compared to the
true differences in both mean and median minor allele frequencies. An empirical p-value
was determined by the proportion of values from the null distribution that are greater than
the observed (original) difference.
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CHAPTER THREE: CSE EXPOSURE PROMOTES GENOMIC INSTABILITY
AND BACTERIAL EVOLUTION.

Results

CSE Induces Point Mutations in P. gingivalis

Complete genomic sequences of control and CSE-exposed P. gingivalis (after 50
passages in GAM-CSE) were obtained using the Illumina HiSeq2000 sequencing
platform, using paired end sequencing with reads approximately 100 base-pairs long. It is
important to acknowledge that the final whole genome sequence for this experiment is
representative of a composite genome of all CSE-induced alterations to P. gingivalis
extant after 50 passages. Considering, after prolonged passaging in CSE, there were
likely to be multiple mutations induced in individual replicating bacterial cells. Naturally,
many of these mutations will have been further propagated. Therefore, the final microbial
population is likely to be composed of a variety of chromosomal sequences and should
not be considered a single entity.
Keeping this in mind, CSE proved to be an environmental stressor capable of
inducing 22 (p<0.05) point mutations as presented in Table 1:
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TABLE 1: Statistically Significant Mutations
Position
2282335
2068758
1463982
2307777
1707468
2068683
2068587
1371743
2068514
275989
1963511
2068717
2068645
2068720
1963452
1963451
2068718
1963860
1963868
599501
2068540
2049674

p-value
0
7.38E-99
1.04E-92
1.06E-79
3.76E-42
5.04E-41
1.63E-32
1.00E-23
4.78E-16
1.99E-15
3.95E-10
5.81E-10
3.24E-09
1.26E-08
2.29E-06
4.39E-06
0.001
0.001
0.008
0.014
0.017
0.034

Confirmation of Point Mutations
We were able to confirm 17/22 (77%) mutations from Table 1 using: (i) - visual
inspection; (ii) – BLASTn; and (iii) – allele-specific PCR [described previously in
Methods]. Due to several variants being located within highly repetitive DNA sequence
patterns - which does not allow for effective primer design - allele-specific PCR was only
employed for three positions as shown in Table 2 and Table 3.
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Table 2: Primer design for allele-specific PCR
Position
Sequence Forward Primer
Sequence Reverse Primer (5’-3’)
(5’-3’)
TATTTTTCGTGGGGCAAGATG
1707468 CATGCT CATCGGTATTCTTG

2282335

2307777

TATGCTGCTTTCTACTGCCCA

CTCCCTATCGTATCTCTCTAG
(Deletion)
GTGAGGAACGCCACGCCT

CTATCCTGACTTTGTCGTCGG

GTGAGGAACGCCACGCCC
(C Allele)
AGTCGAAGAGCTGCTTTTTTTC
AGTCGAAGAGCTGCTTTTTTC
(Deletion)

Table 3: Allele-specific real-time PCR ΔCt Values
GAM control culture
50th passage in CSE
Position
Ct Regular
Ct Variant
ΔCt
Ct Regular
Ct Variant
Allele
Allele
Allele
Allele
1707468
11.91
24.60
12.69
12.65
12.26
2282335
11.89
14.72
2.83
15.83
11.24
2307777
17.08
16.10
-0.98
18.15
14.45

ΔCt
-0.39
-4.59
-3.7

The negative CSE ΔCt values in Table 3 represent a higher amount of variant
allele present than the reference allele and control culteres as given by, (Ctvariant –
Ctcontrol = ΔCt). values The 17 mutations spanned across the entire genome and were
comprised of four deletions, three insertions, and ten Single Nucleotide Polymorphisms
(SNPs) accounting for 18%, 23%, and 59%, respectively as shown in Tables 4-6 below.
TABLE 4: Deletions
Position Gene
Function
2307777 PG2200 hypothetical protein
1707468 IGR
-2068587
2068514

IGR
IGR

Deletion
T
ATCTTGCCCCACGAAAAATAGA
TTAAACTCATTCTCGGAACGCA
CTCTAAATCAA
TACGGAC
TACGGAC

---
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TABLE 5: Insertions
Position
Gene
2068717
IGR
2068645
IGR
2068540
IGR

Function
----

Insertion
G
AGTAAT
CAG

TABLE 6: Single Nucleotide Polymorphisms (SNPs)
Position
Gene
Function
Control
2282335
PG2174
hypothetical protein
T
2068758
IGR
-T
2068683
IGR
-A
1963511
PG1864
leucine-rich protein
A
2068720
IGR
-A
1963452
PG1864
leucine-rich protein
T
1963451
PG1864
leucine-rich protein
G
2068718
IGR
-C
1963860
PG1864
leucine-rich protein
T
1963868
PG1864
leucine-rich protein
T

Mutation
C
A
C
T
T
A
T
A
C
G

Five of the seven gene-based point mutations (71%) were SNPs located within
PG1864, a leucine-rich protein.

The other two gene-based mutations were located

individually within PG2174 (SNP) and PG2200 (Deletion) both of which are hypothetical
proteins.

CSE-exposure increases minor allele frequency (read variance) in P. gingivalis
The mean- and median- percent variation from the major allele was calculated
across all nucleotides separately for both CSE and control samples genomes. Simulated
allele counts were generated at each position using an averaged minor allele frequency
between CSE and control samples. Each nucleotide was treated as independent. Minor
allele frequencies were then averaged across the genome for each of these simulated CSE
and control genome counts. This was repeated 1000 times, and then this distribution of
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differences between CSE and control compared to the true differences in both mean and
median minor allele frequencies. The results are as shown in Table 7 below as
proportions, rather than percentages.
TABLE 7: WGS Read Allele Variance
Control
CSE

Mean
0.00266653
0.00271093

Median
0.00147384
0.00149813

CSE samples had slightly higher mean and median variance than control samples,
which was determined to be significant (p < 0.001) in comparison to control samples.

Discussion

Cigarette smoking increases vulnerability to P. gingivalis infection and increases
susceptibility to periodontitis, but reduces clinical signs of overt inﬂammation. The
underlying mechanisms involved in this clinical conundrum are still being investigated
and remain to be determined. However, it has been hypothesized that cigarette smoke
suppresses host immunity while in contributing to increased bacterial virulence [17].
Several studies have already implicated tobacco smoke in increasing the virulence of P.
gingivalis. We know from previous data that genetic expression of P. gingivalis is
differentially regulated upon exposure to CSE. Major fimbrial genes (PG2133, PG2134)
were induced, while several genes associated with capsular biosynthesis (capK, wecC,
PG0117, PG0118) were suppressed [115,126]. Evidence also suggests tobacco smoke has
the ability to induce alterations to the Lipid A region of P. gingivalis LPS reducing
inflammatory potential, therefore increasing virulence and promoting proliferation [127].
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It has also been shown that tobacco smoke contains several toxic chemicals as
well as the capacity to generate reactive oxygen species [5-7] which have damaging
effects on bacterial DNA [90-92]. The previous microarray study [115] also indicated the
up-regulation of several genes encoding proteins involved in DNA replication,
translocation, and repair.
Our experimental results show that P. gingivalis exposure to CSE promotes
genomic instability by inducing 17 point mutations as well as inducing statistically
significant (p<0.001) read variance. After only 50 passages of exposure over a 23.5Mb
genome, our results imply considerable potential for genetic variance in P. gingivalis
induced by CSE, which is in line with our hypothesis.
Given the relatively small number of significant point mutations across the entire
P. gingivalis genome, striking clusters were noted in certain regions. For example, nine
of the observed variants occur in the region between 2068514 and 2068758 (IGR-[2]**),
while five occurred in the region between 1963451 and 1963868 (PG1864*) as shown in
Figure 2 [135] below.

41

As for the limitations of the whole genome sequencing used in this project
(Illumina HiSeq2000), the short read technology (read length of approximately 100
bases) isn't optimal for characterizing regions with tandem repeats. Complementary,
longer read technologies such as the ionTorrent, ionProton, or better still, PacBio will
remove much of the ambiguity, and as a result will significantly improve our ability to
characterize these regions.
We also did not explore whether CSE exposure additionally causes epigenetic
changes, altering the activity of DNA by chemical modifications of DNA or histone
proteins, for example by affecting methyl or acetyl adducts. Such information would
provide additional valuable information and warrants future investigation to clarify the
influence of cigarette smoke on the epigenetic level.
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In summary, smokers are more prone to infection with P. gingivalis and to
develop periodontitis, yet exhibit reduced clinical inﬂammation.

Our experimental

results gives further evidence to that cigarette smoke is an important driving force for
bacterial evolution. We have found that Porphyromonas gingivalis’ response to CSE
exposure results in genome wide allele variance and point mutations. These results may
explain in part the effects tobacco smoke in altering the virulence of this key periodontal
pathogen that may contribute to the emergence of more virulent strains, which may infect
smokers

and

non-smokers
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alike.

REFERENCES
1. Smoking-attributable mortality, years of potential life lost, and productivity
losses--United States, 2000-2004. MMWR Morb Mortal Wkly Rep, 2008. 57(45):
p. 1226-8.
2. Brown, L., B. Johns, and T. Wall, The economics of periodontal diseases.
Periodontol 2000, 2002. 29: p. 223-34.
3. Jha, P., F. J. Chaloupka, M. Corrao, and B. Jacob. 2006. Reducing the burden of
smoking world-wide: effectiveness of interventions and their coverage. Drug
Alcohol Rev 25:597-609.
4. Petersen, P.E., Tobacco and oral health--the role of the world health
organization. Oral Health Prev Dent, 2003. 1(4): p. 309-15.
5. Mehta, H., K. Nazzal, and R.T. Sadikot, Cigarette smoking and innate immunity.
Inflamm Res, 2008. 57(11): p. 497-503.
6. Stampfli, M. and G. Anderson, How cigarette smoke skews immune responses to
promote infection, lung disease and cancer. Nat Rev Immunol, 2009. 9(5): p.
377-84.
7. Gilmour, M. I., M. S. Jaakkola, S. J. London, A. E. Nel, and C. A. Rogers. 2006.
How exposure to tobacco smoke, outdoor air pollutants, and increased pollen
burdens influences the incidence of asthma. Environ Health Perspect 114:627633.
8. Jha, P., Avoidable global cancer deaths and total deaths from smoking. Nat Rev
Cancer, 2009. 9(9): p. 655-64.
9. Salmasi, G., et al., Environmental tobacco smoke exposure and perinatal
outcomes: a systematic review and meta-analyses. Acta Obstet Gynecol Scand,
2010. 89(4): p. 423-41.
10. Kabir, M.A., K.L. Goh, and M.M. Khan, Adolescent Tobacco Use and Its
Determinants: Evidence From Global Youth Tobacco Survey, Bangladesh 2007.
Asia Pac J Public Health, 2013.
11. Vardavas, C.I. and D.B. Panagiotakos, The causal relationship between passive
smoking and inflammation on the development of cardiovascular disease: a
review of the evidence. Inflamm Allergy Drug Targets, 2009. 8(5): p. 328-33.
12. El-Mohandes, A.A., et al., An intervention to reduce environmental tobacco
smoke exposure improves pregnancy outcomes. Pediatrics, 2010. 125(4): p. 721-8.
13. Wolf, P.A., et al., Cigarette smoking as a risk factor for stroke. The Framingham
Study. JAMA, 1988. 259(7): p. 1025-9.
14. Csordas, A. and D. Bernhard, The biology behind the atherothrombotic effects of
cigarette smoke. Nat Rev Cardiol, 2013.
15. Schroeter, M.R., et al., Cigarette smoke exposure promotes arterial thrombosis
and vessel remodeling after vascular injury in apolipoprotein E-deficient mice. J

44

Vasc Res, 2008. 45(6): p. 480-92.
16. Patel, B.P., et al., Mutagen sensitivity in oral cancer patients, healthy tobacco
chewers and controls. Acta Cytol, 2010. 54(2): p. 169-74.
17. Bagaitkar, J., D.R. Demuth, and D.A. Scott, Tobacco use increases susceptibility
to bacterial infection. Tob Induc Dis, 2008. 4: p. 12.
18. Ezzati, M., et al., Role of smoking in global and regional cardiovascular
mortality. Circulation, 2005. 112(4): p. 489-97.
19. Mercado, C. and E.A. Jaimes, Cigarette smoking as a risk factor for
atherosclerosis and renal disease: novel pathogenic insights. Curr Hypertens
Rep, 2007. 9(1): p. 66-72.
20. Yadav, D. and D.C. Whitcomb, The role of alcohol and smoking in pancreatitis.
Nat Rev Gastroenterol Hepatol, 2010. 7(3): p. 131-45
21. Martins Junior, E.V., et al., [Smoking and inflammatory bowel disease: an
epidemiological case-control study]. Arq Gastroenterol, 1996. 33(2): p. 74-8.
22. Smyk, D.S., et al., Smoking as a risk factor for autoimmune liver disease: what
we can learn from primary biliary cirrhosis. Ann Hepatol, 2012. 11(1): p. 7-14.
23. Baelum, V. and R. Lopez, Defining and classifying periodontitis: need for a
paradigm shift? Eur J Oral Sci, 2003. 111(1): p. 2-6.
24. Pihlstrom, B.L., B.S. Michalowicz, and N.W. Johnson, Periodontal diseases.
Lancet, 2005. 366(9499): p. 1809-20.
25. Huttunen, R., T. Heikkinen, and J. Syrjanen, Smoking and the outcome of
infection. J Intern Med, 2011. 269(3): p. 258-69.
26. Deshpande, A., Epidemiology of community acquired pneumonia. J Assoc
Physicians India, 2012. 60 Suppl: p. 6.
27. Armitage, G.C., Clinical evaluation of periodontal diseases. Periodontol 2000,
1995. 7: p. 39-53.
28. Sopori, M., Effects of cigarette smoke on the immune system. Nat Rev Immunol,
2002. 2(5): p. 372-7.
29. Borrell, L.N. and P.N. Papapanou, Analytical epidemiology of periodontitis. J
Clin Periodontol, 2005. 32 Suppl 6: p. 132-58.
30. Jha, P., et al., 21st-century hazards of smoking and benefits of cessation in the
United States. N Engl J Med, 2013. 368(4): p. 341-50.
31. Kinane, D.F., et al., Human variability in innate immunity. Periodontol 2000,
2007. 45: p. 14-34.
32. Calsina, G., J.M. Ramon, and J.J. Echeverria, Effects of smoking on periodontal
tissues. J Clin Periodontol, 2002. 29(8): p. 771-6.
33. Airila-Mansson, S., B. Soder, and B. Klinge, Bone height changes in individuals
with periodontal disease: a 17-year prospective longitudinal study. J Clin
Periodontol, 2005. 32(7): p. 822-7.
34. Eke, P.I., et al., Prevalence of periodontitis in adults in the United States: 2009
and 2010. J Dent Res, 2012. 91(10): p. 914-20.
35. Bergstrom, J., S. Eliasson, and J. Dock, Exposure to tobacco smoking and
periodontal health. J Clin Periodontol, 2000. 27(1): p. 61-8.
36. Palmer, R.M., et al., Mechanisms of action of environmental factors--tobacco
smoking. J Clin Periodontol, 2005. 32 Suppl 6: p. 180-95.
37. Graves, D., Cytokines that promote periodontal tissue destruction. J Periodontol,

45

2008. 79(8 Suppl): p. 1585-91.
38. Darveau, R.P., A. Tanner, and R.C. Page, The microbial challenge in
periodontitis. Periodontol 2000, 1997. 14: p. 12-32.
39. James, J.A., et al., Effects of tobacco products on the attachment and growth of
periodontal ligament fibroblasts. J Periodontol, 1999. 70(5): p. 518-25.
40. Brusselle, G.G., G.F. Joos, and K.R. Bracke, New insights into the immunology of
chronic obstructive pulmonary disease. Lancet, 2011. 378(9795): p. 1015-26.
41. Rota, M.T., et al., Tobacco smoke in the development and therapy of periodontal
disease: progress and questions. Bull Group Int Rech Sci Stomatol Odontol,
1999. 41(4): p. 116-22.
42. Bullen, C., Impact of tobacco smoking and smoking cessation on cardiovascular
risk and disease. Expert Rev Cardiovasc Ther, 2008. 6(6): p. 883-95.
43. Onozaki, K., Etiological and biological aspects of cigarette smoking in
rheumatoid arthritis. Inflamm Allergy Drug Targets, 2009. 8(5): p. 364-8.
44. Costenbader, K.H. and E.W. Karlson, Cigarette smoking and autoimmune
disease: what can we learn from epidemiology? Lupus, 2006. 15(11): p. 737-45.
45. Nuorti, J.P., et al., Cigarette smoking and invasive pneumococcal disease. Active
Bacterial Core Surveillance Team. N Engl J Med, 2000. 342(10): p. 681-9.
46. Akishima, S., et al., Cigarette-smoke-induced vasoconstriction of peripheral
arteries: evaluation by synchrotron radiation microangiography. Circ J, 2007.
71(3): p. 418-22.
47. Holloway, R.A. and L.E. Donnelly, Immunopathogenesis of chronic obstructive
pulmonary disease. Curr Opin Pulm Med, 2013.
48. Michael Pittilo, R., Cigarette smoking, endothelial injury and cardiovascular
disease. Int J Exp Pathol, 2000. 81(4): p. 219-30.
49. Lehr, H.A., Microcirculatory dysfunction induced by cigarette smoking.
Microcirculation, 2000. 7(6 Pt 1): p. 367-84.
50. Bostanci, N. and G.N. Belibasakis, Porphyromonas gingivalis: an invasive and
evasive opportunistic oral pathogen. FEMS Microbiol Lett, 2012. 333(1): p. 1-9.
51. Peyyala, R., et al., Oral Epithelial Cell Responses to Multispecies Microbial
Biofilms. J Dent Res, 2013.
52. Giannopoulou, C., A. Geinoz, and G. Cimasoni, Effects of nicotine on periodontal
ligament fibroblasts in vitro. J Clin Periodontol, 1999. 26(1): p. 49-55.
53. Chang, Y.C., et al., Adverse effects of arecoline and nicotine on human
periodontal ligament fibroblasts in vitro. J Clin Periodontol, 2001. 28(3): p. 27782.
54. Katono, T., et al., Nicotine treatment induces expression of matrix
metalloproteinases in human osteoblastic Saos-2 cells. Acta Biochim Biophys Sin
(Shanghai), 2006. 38(12): p. 874-82.
55. Chang, Y.C., et al., Induction of c-fos expression by nicotine in human
periodontal ligament fibroblasts is related to cellular thiol levels. J Periodontal
Res, 2003. 38(1): p. 44-50.
56. Scott, D.A. and D.L. Singer, Suppression of overt gingival inflammation in
tobacco smokers - clinical and mechanistic considerations. Int J Dent Hyg, 2004.
2(3): p. 104-10.
57. Scott, D.A. and R.M. Palmer, The influence of tobacco smoking on adhesion

46

molecule profiles. Tob Induc Dis, 2002. 1(1): p. 7-25.
58. Rezavandi, K., et al., Expression of ICAM-1 and E-selectin in gingival tissues of
smokers and non-smokers with periodontitis. J Oral Pathol Med, 2002. 31(1): p.
59-64.
59. Singh, A., et al., The capsule of Porphyromonas gingivalis leads to a reduction in
the host inflammatory response, evasion of phagocytosis, and increase in
virulence. Infect Immun, 2011. 79(11): p. 4533-42.
60. Aduse-Opoku, J., et al., Identification and characterization of the capsular
polysaccharide (K-antigen) locus of Porphyromonas gingivalis. Infect Immun,
2006. 74(1): p. 449-60.
61. Brunner, J., et al., The capsule of Porphyromonas gingivalis reduces the immune
response of human gingival fibroblasts. BMC Microbiol, 2010. 10: p. 5.
62. Yilmaz, Ö., Yao, L., Maeda, K., Rose, T. M., Lewis, E. L., Duman, M., Lamont,
R. J. and Ojcius, D. M. (2008), ATP scavenging by the intracellular
pathogen Porphyromonas gingivalis inhibits P2X7-mediated host-cell apoptosis.
Cellular Microbiology, 10: 863–875. doi: 10.1111/j.1462-5822.2007.01089.x
63. Yilmaz, O., K. Watanabe, and R.J. Lamont, Involvement of integrins in fimbriaemediated binding and invasion by Porphyromonas gingivalis. Cell Microbiol,
2002. 4(5): p. 305-14.
64. Wang, M., et al., Fimbrial proteins of porphyromonas gingivalis mediate in vivo
virulence and exploit TLR2 and complement receptor 3 to persist in macrophages.
J Immunol, 2007. 179(4): p. 2349-58.
65. Paster, B.J., et al., The breadth of bacterial diversity in the human periodontal
pocket and other oral sites. Periodontol 2000, 2006. 42: p. 80-7.
66. Hajishengallis, G. and R.J. Lamont, Beyond the red complex and into more
complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal
disease etiology. Mol Oral Microbiol, 2012. 27(6): p. 409-19.
67. Belton, C.M., et al., Fluorescence image analysis of the association between
Porphyromonas gingivalis and gingival epithelial cells. Cell Microbiol, 1999.
1(3): p. 215-23.
68. Laine, M.L., B.J. Appelmelk, and A.J. van Winkelhoff, Prevalence and
distribution of six capsular serotypes of Porphyromonas gingivalis in
periodontitis patients. J Dent Res, 1997. 76(12): p. 1840-4.
69. Potempa, J. and J. Travis, Porphyromonas gingivalis proteinases in periodontitis,
a review. Acta Biochim Pol, 1996. 43(3): p. 455-65.
70. Chen, T., et al., Porphyromonas gingivalis gingipains and adhesion to epithelial
cells. Infect Immun, 2001. 69(5): p. 3048-56.
71. Kitamura, Y., et al., Gingipains in the culture supernatant of Porphyromonas
gingivalis cleave CD4 and CD8 on human T cells. J Periodontal Res, 2002. 37(6):
p. 464-8.
72. Ozmeric, N., N.R. Preus, and I. Olsen, Genetic diversity of Porphyromonas
gingivalis and its possible importance to pathogenicity. Acta Odontol Scand,
2000. 58(4): p. 183-7.
73. Amano, A., et al., Variations of Porphyromonas gingivalis fimbriae in relation to
microbial pathogenesis. J Periodontal Res, 2004. 39(2): p. 136-42.
74. Lamont, R.J. and H.F. Jenkinson, Life below the gum line: pathogenic

47

mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev, 1998. 62(4):
p. 1244-63.
75. Inaba, H., et al., Heterogenic virulence and related factors among clinical isolates
of Porphyromonas gingivalis with type II fimbriae. Oral Microbiol Immunol,
2008. 23(1): p. 29-35.
76. Hajishengallis, G., et al., Complement receptor 3 blockade promotes IL-12mediated clearance of Porphyromonas gingivalis and negates its virulence in
vivo. J Immunol, 2007. 179(4): p. 2359-67.
77. Umemoto, T. and N. Hamada, Characterization of biologically active cell surface
components of a periodontal pathogen. The roles of major and minor fimbriae of
Porphyromonas gingivalis. J Periodontol, 2003. 74(1): p. 119-22.
78. Hasegawa, Y., et al., Anchoring and length regulation of Porphyromonas
gingivalis Mfa1 fimbriae by the downstream gene product Mfa2. Microbiology,
2009. 155(Pt 10): p. 3333-47.
79. Khlgatian, M., et al., Fimbria-dependent activation of cell adhesion molecule
expression in Porphyromonas gingivalis-infected endothelial cells. Infect Immun,
2002. 70(1): p. 257-67.
80. Bainbridge, B.W. and R.P. Darveau, Porphyromonas gingivalis
lipopolysaccharide: an unusual pattern recognition receptor ligand for the innate
host defense system. Acta Odontol Scand, 2001. 59(3): p. 131-8.
81. Wara-Aswapati, N., et al., Induction of Toll-Like Receptor Expression by
Porphyromonas Gingivalis. J Periodontol, 2012.
82. Kadono, H., et al., Inhibition of osteoblastic cell differentiation by
lipopolysaccharide extract from Porphyromonas gingivalis. Infect Immun, 1999.
67(6): p. 2841-6.
83. Liu, B., et al., Role of p38 mitogen-activated protein kinase pathway in
Porphyromonas gingivalis lipopolysaccharide-induced VCAM-1 expression in
human aortic endothelial cells. J Periodontol, 2012. 83(7): p. 955-62.
84. Liu, R., et al., P. gingivalis and E. coli lipopolysaccharides exhibit different
systemic but similar local induction of inflammatory markers. J Periodontol,
2008. 79(7): p. 1241-7.
85. Darveau, R.P., et al., Porphyromonas gingivalis lipopolysaccharide contains
multiple lipid A species that functionally interact with both toll-like receptors 2
and 4. Infect Immun, 2004. 72(9): p. 5041-51.
86. Hajishengallis, G., et al., Pathogen induction of CXCR4/TLR2 cross-talk impairs
host defense function. Proc Natl Acad Sci U S A, 2008. 105(36): p. 13532-7.
87. Nemoto, E., et al., Regulation of cementoblast function by P. gingivalis
lipopolysaccharide via TLR2. J Dent Res, 2006. 85(8): p. 733-8.
88. Dixon, D.R. and R.P. Darveau, Lipopolysaccharide heterogeneity: innate host
responses to bacterial modification of lipid a structure. J Dent Res, 2005. 84(7):
p. 584-95.
89. Al-Qutub, M.N., et al., Hemin-dependent modulation of the lipid A structure of
Porphyromonas gingivalis lipopolysaccharide. Infect Immun, 2006. 74(8): p.
4474-85.
90. Aufderheide, M. and H. Gressmann, Mutagenicity of native cigarette mainstream
smoke and its gas/vapour phase by use of different tester strains and cigarettes in

48

a modified Ames assay. Mutat Res, 2008. 656(1-2): p. 82-7.
91. De Flora, S., et al., Bacterial mutagenicity of cigarette smoke and its interaction
with ethanol. Mutagenesis, 1995. 10(1): p. 47-52.
92. Doolittle, D.J., et al., Comparative studies on the genotoxic activity of mainstream
smoke condensate from cigarettes which burn or only heat tobacco. Environ Mol
Mutagen, 1990. 15(2): p. 93-105.
93. Chen, X., et al., Cigarette smoking, salivary/gingival crevicular fluid cotinine and
periodontal status. A 10-year longitudinal study. J Clin Periodontol, 2001. 28(4):
p. 331-9.
94. Kallberg, H., et al., Smoking is a major preventable risk factor for rheumatoid
arthritis: estimations of risks after various exposures to cigarette smoke. Ann
Rheum Dis, 2011. 70(3): p. 508-11.
95. Carlens, C., et al., Smoking, use of moist snuff, and risk of chronic inflammatory
diseases. Am J Respir Crit Care Med, 2010. 181(11): p. 1217-22.
96. Bernardi, L., et al., Autonomic and cerebrovascular abnormalities in mild COPD
are worsened by chronic smoking. Eur Respir J, 2008. 32(6): p. 1458-65.
97. Gunsolley, J.C., et al., The effect of race, smoking and immunoglobulin allotypes
on IgG subclass concentrations. J Periodontal Res, 1997. 32(4): p. 381-7.
98. Ginns, L.C., et al., T-lymphocyte subsets in smoking and lung cancer: Analysis of
monoclonal antibodies and flow cytometry. Am Rev Respir Dis, 1982. 126(2): p.
265-9.
99. Hoser, G., et al., Flow cytometric evaluation of lymphocyte subpopulations in
BALF of healthy smokers and nonsmokers. Folia Histochem Cytobiol, 1999.
37(1): p. 25-30.
100.
Hoser, G., et al., Flow cytometric evaluation of lymphocyte subpopulations
in BALF of healthy smokers and nonsmokers. Folia Histochem Cytobiol, 1999.
37(1): p. 25-30.
101.
Richardson, M.A., Upper airway complications of cigarette smoking. J
Allergy Clin Immunol, 1988. 81(5 Pt 2): p. 1032-5.
102.
Wang XL, Scott DA: Molecular Mechanisms of Tobacco-Induced
Diseases. 2006.
103.
Dye, J.A. and K.B. Adler, Effects of cigarette smoke on epithelial cells of
the respiratory tract. Thorax, 1994. 49(8): p. 825-34.
104.
McMaster, S.K., et al., Cigarette smoke inhibits macrophage sensing of
Gram-negative bacteria and lipopolysaccharide: relative roles of nicotine and
oxidant stress. Br J Pharmacol, 2008. 153(3): p. 536-43.
105.
Zappacosta, B., et al., Effect of cigarette smoke extract on the
polymorphonuclear leukocytes chemiluminescence: influence of a filter
containing glutathione. Luminescence, 2005. 20(2): p. 73-5.
106.
Sorensen, L.T., et al., Effect of smoking and abstention on oxidative burst
and reactivity of neutrophils and monocytes. Surgery, 2004. 136(5): p. 1047-53.
107.
Robbins, C.S., et al., Cigarette smoke exposure impairs dendritic cell
maturation and T cell proliferation in thoracic lymph nodes of mice. J Immunol,
2008. 180(10): p. 6623-8.
108.
El Ahmer, O.R., et al., The effect of cigarette smoke on adherence of
respiratory pathogens to buccal epithelial cells. FEMS Immunol Med Microbiol,

49

1999. 23(1): p. 27-36.
109.
Zonuz, A.T., et al., Effect of cigarette smoke exposure on the growth of
Streptococcus mutans and Streptococcus sanguis: an in vitro study. Nicotine Tob
Res, 2008. 10(1): p. 63-7.
110.
Nelson, K.E., et al., Complete genome sequence of the oral pathogenic
Bacterium porphyromonas gingivalis strain W83. J Bacteriol, 2003. 185(18): p.
5591-601.
111.
Socransky, S.S., et al., Microbial complexes in subgingival plaque. J Clin
Periodontol, 1998. 25(2): p. 134-44.
112.
Darveau, R.P., G. Hajishengallis, and M.A. Curtis, Porphyromonas
gingivalis as a potential community activist for disease. J Dent Res, 2012. 91(9):
p. 816-20.
113.
Igboin, C.O., A.L. Griffen, and E.J. Leys, Porphyromonas gingivalis
strain diversity. J Clin Microbiol, 2009. 47(10): p. 3073-81.
114.
Griffen, A.L., et al., Porphyromonas gingivalis strain variability and
periodontitis. J Clin Microbiol, 1999. 37(12): p. 4028-33.
115.
Bagaitkar, J., et al., Tobacco-induced alterations to Porphyromonas
gingivalis-host interactions. Environ Microbiol, 2009. 11(5): p. 1242-53.
116.
Kawada, M., et al., Prevalence of Porphyromonas gingivalis in relation to
periodontal status assessed by real-time PCR. Oral Microbiol Immunol, 2004.
19(5): p. 289-92.
117.
Honda, K., Porphyromonas gingivalis sinks teeth into the oral microbiota
and periodontal disease. Cell Host Microbe, 2011. 10(5): p. 423-5.
118.
Genco, C.A., T. Van Dyke, and S. Amar, Animal models for
Porphyromonas gingivalis-mediated periodontal disease. Trends Microbiol,
1998. 6(11): p. 444-9.
119.
Darveau, R.P., Periodontitis: a polymicrobial disruption of host
homeostasis. Nat Rev Microbiol, 2010. 8(7): p. 481-90.
120.
Genco, C.A., T. Van Dyke, and S. Amar, Animal models for
Porphyromonas gingivalis-mediated periodontal disease. Trends Microbiol,
1998. 6(11): p. 444-9.
121.
Hill, D.A. and D. Artis, Intestinal bacteria and the regulation of immune
cell homeostasis. Annu Rev Immunol, 2010. 28: p. 623-67
122.
Round, J.L. and S.K. Mazmanian, The gut microbiota shapes intestinal
immune responses during health and disease. Nat Rev Immunol, 2009. 9(5): p.
313-23.
123.
Haffajee, A.D., et al., The effect of SRP on the clinical and
microbiological parameters of periodontal diseases. J Clin Periodontol, 1997.
24(5): p. 324-34.
124.
Bagaitkar, J., et al., Tobacco smoke augments Porphyromonas gingivalisStreptococcus gordonii biofilm formation. PLoS One, 2011. 6(11): p. e27386.
125.
Davey, M.E. and M.J. Duncan, Enhanced biofilm formation and loss of
capsule synthesis: deletion of a putative glycosyltransferase in Porphyromonas
gingivalis. J Bacteriol, 2006. 188(15): p. 5510-23.
126.
Bagaitkar, J., et al., Tobacco upregulates P. gingivalis fimbrial proteins
which induce TLR2 hyposensitivity. PLoS One, 2010. 5(5): p. e9323.

50

127.
Buduneli, N., et al., Fatty acid profiles in smokers with chronic
periodontitis. J Dent Res, 2011. 90(1): p. 47-52.
128.
Dixon, D.R. and R.P. Darveau, Lipopolysaccharide heterogeneity: innate
host responses to bacterial modification of lipid a structure. J Dent Res, 2005.
84(7): p. 584-95.
129.
Herath, T.D., et al., Porphyromonas gingivalis lipopolysaccharide lipid A
heterogeneity differentially modulates the expression of IL-6 and IL-8 in human
gingival fibroblasts. J Clin Periodontol, 2011. 38(8): p. 694-701.
130.
Jin, L.J., et al., Global oral health inequalities: task group--periodontal
disease. Adv Dent Res, 2011. 23(2): p. 221-6.
131.
Huang da, W., B.T. Sherman, and R.A. Lempicki, Bioinformatics
enrichment tools: paths toward the comprehensive functional analysis of large
gene lists. Nucleic Acids Res, 2009. 37(1): p. 1-13.
132.
Huang da, W., B.T. Sherman, and R.A. Lempicki, Systematic and
integrative analysis of large gene lists using DAVID bioinformatics resources.
Nat Protoc, 2009. 4(1): p. 44-57.
133.
Fraser, H.S., et al., Elevated systemic concentrations of soluble ICAM-1
(sICAM) are not reflected in the gingival crevicular fluid of smokers with
periodontitis. J Dent Res, 2001. 80(7): p. 1643-7.
134.
Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical
and powerful approach to multiple testing. J R Stat Soc 1995, 57:289-300.
135.
Stothard P, Wishart DS. Circular genome visualization and exploration
using CGView. Bioinformatics 21:537-539.
136.
Calero O, Hortigüela R, Bullido MJ, Calero M. J Neurosci Methods. 2009
Oct 15;183(2):238-40. doi: 10.1016/j.jneumeth.2009.06.033. Epub 2009 Jul 5.

51

CURRICULUM VITAE

Education
•

The Ohio State University
2005-2007

A.A.

•

University of Kentucky
2008-2011

B.S. Biology

•

University of Louisville
2011-Present

M.S. Oral Biology Candidate

Research Experience

Virology Study (Undergrad-UK)
It was hypothesized that Human Herpes Virus (HHV) promotes and increases the
risk of periodontal infections. Based on conflicting data, the goal of this research project
was to study the potential role that HHVs play in periodontal disease using an
experimental rat model.
To examine this question my mentor and I studied the influence of rat
cytomegalovirus (RCMV), on the development of periodontitis using a rat model of
periodontal disease. RCMV is genetically related to human cytomegalovirus, one of the
most common types of herpes virus found at sites of periodontal infection. Our research
investigated how the time-course of acquisition of RCMV infection influenced the
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progression of periodontal disease in rats colonized with a human periodontitis bacterial
strain, Porphyromonas gingivalis.
Two experiments were designed to investigate potential interactions between
these agents in promoting periodontitis in immunocompetent (Study-1) and
immunosuppressed rats (Study-2). In these studies, 4-5 week-old rats were placed in and
control and experimental treatment groups and inoculated with RCMV, P. gingivalis, or
both agents at varying time-points. The RCMV was given by intraperitoneal injection and
the P. gingivalis by oral gavage. Blood samples for determination of immune responses
were collected at the start of the experiment and at approximate monthly intervals during
the 4-month time-course of the experiment. At these times anesthetic was administered to
allow for the collection of dental plaque samples to characterize the inflammatory profile
of the rat periodontal tissues and to determine the persistence of P. gingivalis and/or
RCMV in the oral cavity. At the end of each experiment the rats will be euthanatized by
inhalation of CO2 gas. Gingival (periodontal) tissues will be excised for histological and
molecular analysis and the mandibles and maxillary bones removed for radiographic
evaluation of alveolar bone loss related to periodontal disease.
Rats in the second study, modeling periodontal disease in immunosuppressed
hosts (e.g. cancer, AIDS, or organ transplant patients), were treated with whole body
irradiation or immunosuppressive drugs to impair their immune system. The rats were
divided into similar treatment groups and diagnostically sampled like rats in Study-1.
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Telomere Study (Undergrad-UK)
In this independent research project I hypothesized the function of spatially
clustered telomere end genes of an Aspergillus nidulans (fungus) chromosome served a
functionally common purpose based on preliminary data which, indicated they were
involved with metabolic/growth function. To test this theory I used software programs
and bioinformatics databases such as Broad Institute, BLAST, and Vector NTI to
sequence the genes in question, compare them against phylotypically related species to
try and determine a predicted function for each gene. From these sequences, primers for
DNA polymerase reactions were designed to construct gene knockouts. The knockouts
were then used to test the functionality of each of the 6 identified genes I was examining,
independently and together to try and determine their individual function and a possible
hypothesized common function.

Effects of gene knockouts were measured

morphologically compared to control A. nidulans colonies.
Future Academic Plans
After completing this Master’s Degree, I will be attending the University of
Kentucky College of Dentistry beginning the fall 2013 semester and graduate with the
Doctor of Medical Dentistry (DMD) Class of 2017.
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